| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2015/278591 |
| P8608 | Fatcat ID | release_mi3xudmwybcgdhioik2of6alwi |
| P932 | PMC publication ID | 4359801 |
| P698 | PubMed publication ID | 25815012 |
| P5875 | ResearchGate publication ID | 274312712 |
| P2093 | author name string | Yakup Yalcin | |
| Serenat Eris | |||
| Ahmet Zeki Isik | |||
| Pelin Ozun Ozbay | |||
| Selda Uysal | |||
| Seyran Yigit | |||
| P2860 | cites work | Metformin in polycystic ovary syndrome: systematic review and meta-analysis | Q22242098 |
| Consensus on infertility treatment related to polycystic ovary syndrome | Q22242888 | ||
| Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations | Q28290647 | ||
| Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome | Q32131281 | ||
| Effects of metformin on early pregnancy loss in the polycystic ovary syndrome | Q34113427 | ||
| Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). | Q34285382 | ||
| Glycodelin in reproductive endocrinology and hormone-related cancer | Q34657737 | ||
| The role of glycodelin as an immune-modulating agent at the feto-maternal interface | Q34659419 | ||
| Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus | Q35751121 | ||
| A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome | Q36557607 | ||
| The metabolic effects of drugs used for the treatment of polycystic ovary syndrome | Q37591848 | ||
| Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome | Q37617768 | ||
| Global gene profiling in human endometrium during the window of implantation | Q38289149 | ||
| Oligosaccharides modulate the apoptotic activity of glycodelin | Q38311351 | ||
| Structural studies, localization in tissue and clinical aspects of human endometrial proteins | Q39542166 | ||
| Hypersecretion of luteinising hormone, infertility, and miscarriage | Q44059853 | ||
| Glycodelin A, not glycodelin S, is apoptotically active. Relevance of sialic acid modification | Q44695957 | ||
| Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy | Q44757155 | ||
| Endometrial glycodelin-A expression in the luteal phase of stimulated ovarian cycles | Q44873881 | ||
| Correlation of serum and follicular fluid concentrations of placental protein 14 and CA-125 in in vitro fertilization-embryo transfer patients | Q48985353 | ||
| Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage | Q49143386 | ||
| Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles. | Q50858562 | ||
| Endometrial protein PP14 and CA-125 in recurrent miscarriage patients; correlation with pregnancy outcome. | Q53790135 | ||
| Concentration of endometrial protein PP14 in uterine flushings throughout the menstrual cycle in normal, fertile women | Q59830946 | ||
| A comparative study of glycodelin concentrations in uterine flushings in women with subseptate uteri, history of unexplained recurrent miscarriage and healthy controls | Q61842221 | ||
| Secretory endometrium synthesizes placental protein 14 | Q68872289 | ||
| Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle | Q72629950 | ||
| Subfertility and risk of spontaneous abortion | Q74304986 | ||
| Glycodelin A is expressed differentially in normal human endometrial tissue throughout the menstrual cycle as assessed by immunohistochemistry and in situ hybridization | Q79310965 | ||
| [Glycodelin in IVF-ET cycles: its association with endometrial receptivity and impact on the outcome of pregnancy] | Q80183956 | ||
| Glycodelin is present in pinopodes of receptive-phase human endometrium and is associated with down-regulation of progesterone receptor B | Q83945613 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | metformin | Q19484 |
| clomifene | Q418730 | ||
| polycystic ovary syndrome | Q500816 | ||
| polycystic ovary | Q5547896 | ||
| pregnancy outcome | Q66057507 | ||
| P304 | page(s) | 278591 | |
| P577 | publication date | 2015-02-28 | |
| P1433 | published in | Obstetrics and gynecology international | Q26842470 |
| P1476 | title | Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study | |
| P478 | volume | 2015 |
| Q33743109 | Pharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: A review of the literature | cites work | P2860 |
Search more.